Our campaign is now complete. 41 supporters helped us raise US$113,681.00
Visit the charity's profile
Organised by Baylor College of MedicineFounded in 1974, Digisonics has always been committed to the health of those we touch through our services. As COVID-19 has paralyzed the globe, we are joining Baylor College of Medicine on its quest to develop a vaccine.
Closed 08/07/2021
The campaign has now expired but it's not too late to support this charity.
Visit the charity's profile
Right now, the novel coronavirus (COVID-19) is continuing its rapid spread worldwide. COVID-19 has reached more than 191 countries, infected hundreds of thousands of people and, most sadly, claimed many lives. One of the concerning situations as to why these coronavirus outbreaks are so devastating is that there is no preventative solution, no vaccine or therapy. Digisonics and CEO Diana McSherry have initiated this vital fund with key donations.
During the 2012 MERS outbreak, The Baylor College of Medicine Team secured federal funding to develop both SARS and MERS vaccines. In 2016, a SARS vaccine candidate was successfully produced, but before it could be tested, a viable SARS treatment was found. As a result, this potential vaccine was shelved. The Baylor College of Medicine Team has identified key similarities in the genetic structures of SARS and COVID-19. The potential SARS vaccine candidate might be a crucial step forward in resolving the current coronavirus health emergency.
Baylor needs your help in funding the testing of this potential vaccine. An estimated $2 - 3 million is required to carry out the full scope of vaccine testing from lab work through toxicity testing and, ultimately, the goal of a human clinical trial. Please consider donating or sharing this message to support this critical work. Click on the Donate button above or see below for the address to mail a check.
Together, we can help Baylor realize their goal of a vaccine to defeat COVID-19 and potentially prevent future coronavirus outbreaks!
Baylor College of Medicine was the founding institution in the Texas Medical Center, now the largest medical center in the world. As the internationally acclaimed academic medical research institution in the Southwest, we are a global leader for biomedical research and patient care. Home to the No. 1 genetics program in the United States, Baylor is relentlessly innovating and creating solutions to this present crisis.
Peter Hotez, M.D., Ph.D., and Maria Elena Bottazzi, Ph.D. are both world-renowned vaccine scientists, and co-directors of its Baylor's Center for Vaccine Development. Dr. Hotez, Dean of Baylor College of Medicine's National School of Tropical Medicine, is acclaimed for his vaccine expertise and has made frequent appearances on hundreds of national and international news outlets. Dr. Bottazzi, Associate Dean of the National School of Tropical Medicine, was recently named as one of 10 Emerging Leaders in Health and Medicine Scholars by the National Academy of Medicine. Together, Drs. Hotez and Bottazzi have joined forces to develop vaccines for some of the worlds most threatening infectious diseases.
Digisonics and CEO Diana McSherry have initiated this vital fund with key donations.
Charities pay a small fee for our service. Learn more about fees